FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Bumetanide Injection
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Fresenius Kabi USA, LLC (Revised 05/08/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, .25 mg/1 mL (NDC 65219-570-04)	Unavailable	Backordered. Next release May 2024.	Delay in shipping of the drug
Injection, .25 mg/1 mL (NDC 65219-572-10)	Available	Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Revised 05/17/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, .25 mg/1 mL (NDC 0641-6008-10)	Available
Injection, .25 mg/1 mL (NDC 0641-6007-10)	Available

MSN Laboratories Private Limited (Reverified 12/19/2023)

Company Contact Information:
Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01)	Available
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-101-07)	Available
Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)	Available
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07)	Available

Sagent Pharmaceuticals (Reverified 05/18/2024)

Company Contact Information:
866-625-1618

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 70860-405-04)	Available
Bumetanide, Injection, .25 mg/1 mL (NDC 70860-406-10)	Available